Back to Search Start Over

Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods

Authors :
Pascal Amedro
Oscar Werner
Hamouda Abassi
Aymeric Boisson
Luc Souilla
Sophie Guillaumont
Johanna Calderon
Anne Requirand
Marie Vincenti
Victor Pommier
Stefan Matecki
Gregoire De La Villeon
Kathleen Lavastre
Alain Lacampagne
Marie-Christine Picot
Constance Beyler
Christophe Delclaux
Yves Dulac
Aitor Guitarte
Philippe Charron
Isabelle Denjoy-Urbain
Vincent Probst
Alban-Elouen Baruteau
Philippe Chevalier
Sylvie Di Filippo
Jean-Benoit Thambo
Damien Bonnet
Jean-Luc Pasquie
Source :
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-9 (2021)
Publication Year :
2021
Publisher :
BMC, 2021.

Abstract

Abstract Background Advances in paediatric cardiology have improved the prognosis of children with inherited cardiac disorders. However, health-related quality of life (QoL) and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardiomyopathy. Moreover, current guidelines on the eligibility of young athletes with inherited cardiac disorders for sports participation mainly rely on expert opinions and remain controversial. Methods The QUALIMYORYTHM trial is a multicentre observational controlled study. The main objective is to compare the QoL of children aged 6 to 17 years old with inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or arrhythmogenic right ventricular dysplasia), or inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy), to that of age and gender-matched healthy subjects. The secondary objective is to assess their QoL according to the disease’s clinical and genetic characteristics, the level of physical activity and motivation for sports, the exercise capacity, and the socio-demographic data. Participants will wear a fitness tracker (ActiGraph GT3X accelerometer) for 2 weeks. A total of 214 children are required to observe a significant difference of 7 ± 15 points in the PedsQL, with a power of 90% and an alpha risk of 5%. Discussion After focusing on the survival in children with inherited cardiac disorders, current research is expanding to patient-reported outcomes and secondary prevention. The QUALIMYORYTHM trial intends to improve the level of evidence for future guidelines on sports eligibility in this population. Trial registration ClinicalTrials.gov Identifier: NCT04712136, registered on January 15th, 2021 ( https://clinicaltrials.gov/ct2/show/NCT04712136 ).

Details

Language :
English
ISSN :
14777525
Volume :
19
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Health and Quality of Life Outcomes
Publication Type :
Academic Journal
Accession number :
edsdoj.56b3be256d042baaf62bc952e6d1f50
Document Type :
article
Full Text :
https://doi.org/10.1186/s12955-021-01825-6